This site has been created solely for the purpose of providing information about services available from Richmond Pharmacology. The site has been compiled in good faith from information available at the time and is therefore subject to change at any time and without notification.
Mission Statement
Our Mission Statement guides our employees, volunteers and stakeholders and outlines our goals and objectives as an organisation.
Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease
June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.